CLARIANT AG-UNSPONSORED ADR Business Summary

Clariant AG (CLZNY) is a global specialty chemical company that generates revenue through the development, manufacture, and distribution of high-value chemical products across three primary segments: Care Chemicals, Catalysts, and Adsorbents & Additives. The Care Chemicals division targets consumer-facing markets like personal care and home care, while the Catalysts and Adsorbents & Additives segments provide critical solutions for the energy, mining, and industrial sectors. As of mid-2026, the company operates on a value-based pricing model, focusing on high-margin, sustainability-driven innovation to mitigate geopolitical volatility and inflationary pressures in raw materials. Clariant competes directly with global peers such as BASF, Croda International, and Johnson Matthey, positioning itself as a specialized, sustainability-focused player with a leaner portfolio following strategic divestments of its lower-margin pigments and masterbatches businesses. Originally formed as a spin-off from Sandoz in 1995, Clariant is currently led by Chief Executive Officer Conrad Keijzer, who joined in 2021 with a background as CEO of Imerys and an executive at AkzoNobel. The leadership team includes Chief Financial Officer Oliver Rittgen and key business presidents such as Angela Cackovich (Adsorbents & Additives) and Marcelo Lu, who was appointed in early 2026 to lead the Care Chemicals & Americas division. The Board of Directors is chaired by Ben van Beurden, the former CEO of Shell, and includes notable members such as Albert Manifold, Chairman of BP, and Regula Wallimann. The company maintains a diverse institutional investor base with no single controlling shareholder, emphasizing a governance-led structure focused on achieving its 2027 medium-term financial targets.